Covid-19 roundup: EU and As­traZeneca trade blows over slow­downs; Un­usu­al unions pop up to test an­ti­bod­ies, vac­cines

Af­ter com­ing un­der fire for man­u­fac­tur­ing de­lays last week, As­traZeneca’s feud with the Eu­ro­pean Union has spilled in­to the open.

The bloc ac­cused the phar­ma gi­ant on Wednes­day of pulling out of a meet­ing to dis­cuss cuts to its vac­cine sup­plies, the AP re­port­ed. As­traZeneca de­nied the re­ports, say­ing it still planned on at­tend­ing the dis­cus­sion.

Ear­ly Wednes­day, an EU Com­mis­sion spokes­woman said that “the rep­re­sen­ta­tive of As­traZeneca had an­nounced this morn­ing, had in­formed us this morn­ing that their par­tic­i­pa­tion is not con­firmed, is not hap­pen­ing.” But an As­traZeneca spokesper­son lat­er called the re­ports “not ac­cu­rate.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.